top of page
Screen Shot 2020-12-15 at 7.07.31 AM.png

SURGX

SURGX is a powerful antimicrobial gel designed to reduce surgical site and post-surgical infections by destroying planktonic and biofilm encased bacteria.

Using Next Science’s patented, non-toxic XBIO® technology, SURGX conforms to post-operative wounds to prevent surface attachment of free-floating bacteria, eliminate pathogens in the gel and defend against recolonization. The proprietary, non-toxic formulation conforms to the post-operative wound to provide proven broad spectrum and sustained effectiveness for up to 5 days. 

 

surx-shot-1_1-2.jpg

OUR FEATURES

SUSTAINED EFFICACY UP TO 5 DAYS

 

UP TO 7 LOG REDUCTION WITHIN 2 MINUTES

NON-TOXIC

BROAD SPECTRUM EFFICACY

PRODUCT EFFICACY

Studies show SURGX provides broad-spectrum efficacy and multi-log biofilm reduction of MRSA and P. aeruginosa.

COMPETITIVE COMPARISON

SURGX demonstrates up to 5-day efficacy in preventing MRSA bacterial growths.

CLINICAL AND SCIENTIFIC EVIDENCE

SURGX in the role of SSSI prevention

Clinical Assessment of a Biofilm-disrupting Agent for the Management of Chronic Wounds Compared With Standard of Care: A Therapeutic Approach

Disrupting the biofilm matrix improves wound healing outcomes

 

Next Science Wound Gel Technology, a Novel Agent That Inhibits Biofilm Development by Gram-Positive and Gram-Negative Wound Pathogens

bottom of page